Differentiation of skeletal muscle involves an ordered series of morphological and molecular events in which undifferentiated myoblasts exit the cell cycle and fuse to form multi-nucleated myotubes. During this period, an array of muscle-specific genes encoding proteins required for the specialized functions of the mature muscle fiber is induced to high levels. Myogenic differentiation is suppressed by fibroblast growth factor (FGF) and transforming growth factor type-beta (TGF-beta) and by mutationally activated ras proteins, which are postulated to couple growth factor receptors with intracellular effectors. The goals of this project are designed to define more precisely the nuclear targets for the cascades triggered by growth factors and ras proteins and to identify mechanism(s) involved in transcriptional induction of muscle-specific genes during myogenesis. To address this problem, we have isolated the mouse muscle creatine kinase (mck) gene, which is among the tissue-specific genes that are induced during myogenesis. We have also identified a distal upstream enhancer and a weaker intragenic regulatory element confer differentiation-specific and cell-type-restricted expression on this gene. A series of myoblast cell lines that express ras autonomously also has been constructed. The program for differentiation of these cells is subject to negative control by ras. In the present study we propose to fully characterize mck regulatory elements and to determine sites for interaction of specific DNA binding proteins with these elements. The ways in which growth factor and ras-dependent pathways impinge on these mck regulatory factors also will be examined. Finally, we will purify and eventually obtain cDNA clones for mck regulatory factors which will allow investigations into the cascade of regulatory events that controls establishment of the myogenic phenotype.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR039849-05
Application #
3160079
Study Section
Molecular Cytology Study Section (CTY)
Project Start
1989-03-01
Project End
1994-02-28
Budget Start
1993-03-01
Budget End
1994-02-28
Support Year
5
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Parker, S B; Eichele, G; Zhang, P et al. (1995) p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267:1024-7
Lilly, B; Galewsky, S; Firulli, A B et al. (1994) D-MEF2: a MADS box transcription factor expressed in differentiating mesoderm and muscle cell lineages during Drosophila embryogenesis. Proc Natl Acad Sci U S A 91:5662-6
Kuratani, S; Martin, J F; Wawersik, S et al. (1994) The expression pattern of the chick homeobox gene gMHox suggests a role in patterning of the limbs and face and in compartmentalization of somites. Dev Biol 161:357-69
Olson, E N (1993) Regulation of muscle transcription by the MyoD family. The heart of the matter. Circ Res 72:1-6
Staudinger, J; Perry, M; Elledge, S J et al. (1993) Interactions among vertebrate helix-loop-helix proteins in yeast using the two-hybrid system. J Biol Chem 268:4608-11
Edmondson, D G; Olson, E N (1993) Helix-loop-helix proteins as regulators of muscle-specific transcription. J Biol Chem 268:755-8
Martin, J F; Schwarz, J J; Olson, E N (1993) Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors. Proc Natl Acad Sci U S A 90:5282-6
Cserjesi, P; Lilly, B; Bryson, L et al. (1992) MHox: a mesodermally restricted homeodomain protein that binds an essential site in the muscle creatine kinase enhancer. Development 115:1087-101
Li, L; Zhou, J; James, G et al. (1992) FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell 71:1181-94
Chakraborty, T; Martin, J F; Olson, E N (1992) Analysis of the oligomerization of myogenin and E2A products in vivo using a two-hybrid assay system. J Biol Chem 267:17498-501

Showing the most recent 10 out of 13 publications